Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Pediatrics, Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, India.
ANZ J Surg. 2021 Sep;91(9):1819-1825. doi: 10.1111/ans.16517. Epub 2020 Dec 28.
Splenic abscess has been an uncommon entity which is now being encountered more frequently due to increased prevalence of immunodeficiency disorders and chronic illnesses. This study was aimed to audit our experience with splenic abscesses at a tertiary care centre in India highlighting usefulness of an algorithmic approach.
Retrospective analysis of data of patients (January 2014 to December 2019) with splenic abscess was done. Data were retrieved for clinical characteristics, radiological findings, organism spectra, abscess characteristics, therapeutic measures and clinical outcome.
The mean age of the study population (n = 36) was 41.3 ± 19.0 years with 50% males. Comorbidities were identified in 17 (47.2%) patients, with diabetes mellitus being the commonest. Fever and abdominal pain were the most common presenting features. Multiple splenic abscesses were present in 21 (58.3%) patients. Extra-splenic abscesses in liver were seen in five (13.9%) patients while nine (25%) patients had ruptured splenic abscess. Microorganisms were identified in 24 (66.7%) patients, with Salmonella typhi being the commonest (n = 9, 25%) followed by Escherichia coli (n = 7, 19.4%) and Staphylococcus aureus (n = 4, 11.1%). Six patients received only antimicrobials, 24 were managed with percutaneous aspiration or catheter drainage and six required surgery. Five (13.9%) patients died, with highest mortality being seen in those who received only antimicrobial (50%), compared to percutaneous aspiration or catheter drainage (8.3%) and surgery (0%), P = 0.017.
Using percutaneous aspiration or drainage in conjunction with antibiotics, followed by surgery in non-responder, patients with splenic abscesses can be managed successfully with acceptable mortality.
由于免疫功能紊乱和慢性疾病的发病率不断上升,脾脓肿已不再是一种罕见疾病,现在更为常见。本研究旨在回顾性分析在印度一家三级医疗中心治疗脾脓肿的经验,重点介绍一种算法方法的实用性。
对 2014 年 1 月至 2019 年 12 月期间患有脾脓肿的患者(n=36)的数据进行回顾性分析。检索的资料包括临床特征、影像学表现、病原体谱、脓肿特征、治疗措施和临床结局。
研究人群(n=36)的平均年龄为 41.3±19.0 岁,男性占 50%。17 例(47.2%)患者存在合并症,其中糖尿病最常见。发热和腹痛是最常见的首发症状。21 例(58.3%)患者存在多发性脾脓肿。5 例(13.9%)患者合并肝外脾脓肿,9 例(25%)患者为脾脓肿破裂。24 例(66.7%)患者的病原体得以鉴定,其中伤寒沙门氏菌最为常见(n=9,25%),其次为大肠埃希菌(n=7,19.4%)和金黄色葡萄球菌(n=4,11.1%)。6 例患者仅接受抗生素治疗,24 例接受经皮抽吸或导管引流治疗,6 例患者接受手术治疗。5 例(13.9%)患者死亡,仅接受抗生素治疗的患者死亡率最高(50%),明显高于经皮抽吸或导管引流(8.3%)和手术(0%),P=0.017。
脾脓肿患者可采用经皮抽吸或引流联合抗生素治疗,如果患者无反应,再采用手术治疗,可获得较好的治疗结局,死亡率也可被接受。